These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31364436)

  • 41. Distinguishing spontaneous from deliberate mind wandering in adolescents: The role of attentional control and depressive symptoms.
    Vannucci M; Chiorri C; Nocentini A; Menesini E
    Br J Dev Psychol; 2020 Sep; 38(3):434-441. PubMed ID: 32096263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lapses in the Person Radar: ADHD Symptoms Predict Difficulty in Interpersonal Distancing.
    Brown CRH; Forster S
    J Atten Disord; 2023 Feb; 27(4):368-380. PubMed ID: 36642943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Quality of life of patients with attention-deficit/hyperactivity disorder: systematic review of the past 5 years].
    Velő S; Keresztény Á; Szentiványi D; Balázs J
    Neuropsychopharmacol Hung; 2013 Jun; 15(2):73-82. PubMed ID: 23817358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A d factor? Understanding trait distractibility and its relationships with ADHD symptomatology and hyperfocus.
    Zhang H; Miyake A; Osborne J; Shah P; Jonides J
    PLoS One; 2023; 18(10):e0292215. PubMed ID: 37878578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Ng QX
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):112-116. PubMed ID: 27813651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Context Regulation of Mind Wandering in ADHD.
    Bozhilova N; Michelini G; Jones C; Kuntsi J; Rubia K; Asherson P
    J Atten Disord; 2021 Dec; 25(14):2014-2027. PubMed ID: 32942934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are Adult ADHD Patients Good Informants of Their Symptoms? A Qualitative Literature Review of Concordance Between Clinician and Self-Report ADHD Symptoms.
    Abrams J; Faraone SV; Woodworth KY; Spencer TJ; Biederman I; Biederman J
    J Nerv Ment Dis; 2018 Sep; 206(9):739-743. PubMed ID: 30124570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ADHD and Interfering Thoughts in High and Low Conflict Conditions.
    Alali-Morlevy K; Goldfarb L
    J Atten Disord; 2022 Apr; 26(6):843-856. PubMed ID: 34340586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A daily diary study on maladaptive daydreaming, mind wandering, and sleep disturbances: Examining within-person and between-persons relations.
    Marcusson-Clavertz D; West M; Kjell ONE; Somer E
    PLoS One; 2019; 14(11):e0225529. PubMed ID: 31774836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcultural adaptation to Portuguese of the Mind Excessively Wandering Scale (MEWS) for evaluation of thought activity.
    Figueiredo T; Erthal P; Fortes D; Asherson P; Mattos P
    Trends Psychiatry Psychother; 2018; 40(4):337-341. PubMed ID: 30234888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pragmatic language difficulties in children with hyperactivity and attention problems: an integrated review.
    Green BC; Johnson KA; Bretherton L
    Int J Lang Commun Disord; 2014; 49(1):15-29. PubMed ID: 24372883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distracted by your mind? Individual differences in distractibility predict mind wandering.
    Forster S; Lavie N
    J Exp Psychol Learn Mem Cogn; 2014 Jan; 40(1):251-260. PubMed ID: 23957365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can research participants comment authoritatively on the validity of their self-reports of mind wandering and task engagement?
    Seli P; Jonker TR; Cheyne JA; Cortes K; Smilek D
    J Exp Psychol Hum Percept Perform; 2015 Jun; 41(3):703-709. PubMed ID: 25665082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-Term Suicide Risk of Children and Adolescents With Attention Deficit and Hyperactivity Disorder-A Systematic Review.
    Garas P; Balazs J
    Front Psychiatry; 2020; 11():557909. PubMed ID: 33408650
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.
    Moukhtarian TR; Cooper RE; Vassos E; Moran P; Asherson P
    Eur Psychiatry; 2017 Jul; 44():198-207. PubMed ID: 28646732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
    Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
    Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.
    Sergeant J
    Neurosci Biobehav Rev; 2000 Jan; 24(1):7-12. PubMed ID: 10654654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attention deficit hyperactivity symptoms and disorder (ADHD) among African children: a review of epidemiology and co-morbidities.
    Bakare MO
    Afr J Psychiatry (Johannesbg); 2012 Sep; 15(5):358-61. PubMed ID: 23044891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Field of daydreams? Integrating mind wandering in the study of sluggish cognitive tempo and ADHD.
    Becker SP; Barkley RA
    JCPP Adv; 2021 Apr; 1(1):e12002. PubMed ID: 37431506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.